Susanna Gatti High, Chief Operating Officer at Dyne Therapeutics, Inc. (DYN), sold 19,878 shares at $7.40 ($147K) on 2023-11-02, disclosed to the SEC on 2023-11-02.
Open-market sale of $147k DYN by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.40 | 9,939 | $74K | 50.0% |
| 2 | $7.40 | 9,939 | $74K | 50.0% |
| Total | $7.40 avg | 19,878 | $147K | 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $248K | — | Filing → |
| DYN | SELL | 2024-07-03 | $722K | — | Filing → |
| DYN | SELL | 2024-06-24 | $2.4M | — | Filing → |